mHealth Solutions Market
完整報告名稱與涵蓋範圍
mHealth Solutions Market by Offering [Apps (Chronic Care, Mental Health, Women's Health, Medication Management, Fitness, CDS), Devices (Sleep, Drug Delivery)], Use Case (Preventive, Monitoring), End User (Providers, Patients) - Global Forecast to 2031
報告摘要
The global mHealth solutions market is forecast to reach USD 275.44 billion by 2031, up from USD 109.05 billion in 2026, at a CAGR of 20.4% over the forecast period. Government policies and regulatory initiatives increasingly support the adoption of mHealth solutions by establishing frameworks for mobile medical applications, connected medical devices, remote patient monitoring, AI-enabled healthcare software, and digital health infrastructure. In the US, the FDA applies a risk-based regulatory framework to mobile medical applications and device software, while recent 2026 guidance on clinical decision support software and low-risk wellness technologies provides greater clarity for digital health developers. In addition, the FDA launched the TEMPO Digital Health Devices Pilot in 2026 to promote access to certain digital health devices while maintaining patient safety requirements. The Australian Digital Health Agency has developed a national Assessment Framework for mHealth Apps to help consumers and healthcare professionals assess the credibility, safety, usability, and clinical value of mobile health applications. These initiatives provide greater regulatory clarity and confidence around mHealth applications, supporting their development, evaluation, and adoption across the healthcare system.
By offering, the mHealth services segment is growing at a significant rate during the forecast period.
mHealth services are experiencing significant growth as healthcare systems increasingly adopt technology-enabled models for continuous, remote, and home-based care. This expansion is driven by the growing prevalence of chronic diseases, the need for continuous patient monitoring, rising demand for home healthcare, and the increasing use of connected medical devices that transmit health information to healthcare providers. For example, Philips' Care Orchestrator enables healthcare providers to remotely monitor and manage patients with sleep apnea and respiratory conditions, receive adherence and clinical reports, and prioritize patients who require intervention.
By end user, the healthcare providers segment held a significant share of the MHealth solutions market in 2025.
By end user, the mHealth solutions market is segmented into patients/consumers, healthcare providers, healthcare payers, and other end users. This segmentation is driven by the growing adoption of digital technologies to improve patient monitoring, clinical decision-making, care coordination, and healthcare delivery. Hospitals, clinics, and other healthcare providers are increasingly integrating mHealth applications, connected medical devices, and remote monitoring services into clinical workflows to enable continuous access to patient data and support timely interventions. The rising prevalence of chronic diseases and the shift toward value-based and home-based care are further encouraging healthcare providers to adopt mHealth solutions. For example, remote patient monitoring enables providers to receive patient-generated health data from connected devices such as blood pressure monitors, glucose monitors, and pulse oximeters, and to use this information to manage patients remotely.
Asia Pacific is expected to register the fastest growth during the forecast period.
Asia Pacific is expected to be the fastest-growing region in the mHealth solutions market, supported by rapid digitalization of healthcare, expanding mobile connectivity, rising chronic disease burden, and increasing demand for remote and home-based care. Government initiatives across the region are further strengthening the digital-health ecosystem. In China, the government continues to expand the “Internet + Healthcare” model, with internet hospitals and online medical services increasing access to remote consultations and digitally enabled care. By 2025, China's internet-healthcare regulatory platform had achieved provincial-level coverage, and the number of internet hospitals had increased significantly. The government is also promoting mobile medical applications, remote consultations, and connected healthcare services, including through the “Broadband Network + Healthy Rural Areas” pilot, which included 117 projects, of which 37 focused on remote medical services. These initiatives are strengthening the region's digital-health infrastructure and creating opportunities for mHealth applications, telehealth, remote patient monitoring, and connected medical devices.
The break-down of primary participants is as mentioned below:
• By Company Type - Tier 1: 32%, Tier 2: 44%, and Tier 3: 24%
• By Designation - Directors: 30%, Manager: 34%, and Others: 36%
• By Region - North America: 40%, Europe: 28%, Asia Pacific: 20%, Latin America: 7% and Middle East & Africa: 5%
Key Players
The prominent players operating in the mHealth solutions market include Koninklijke Philips N.V. (Netherlands), Medtronic (Ireland), Abbott (US), ResMed (US), Dexcom, Inc. (US), GE HealthCare (US), athenahealth (US), Optum (US), among others. These companies adopted strategies such as product launches, product updates, expansions, partnerships, collaborations, and mergers & acquisitions to strengthen their presence in the mHealth solutions market.
Research Coverage
The report analyzes the mHealth solutions market and estimates the market size and future growth potential of various segments based on offering, use case, end user, and region. The report also analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It evaluates opportunities and challenges for market stakeholders. The report also studies micro-markets with respect to their growth trends, prospects, and contributions to the total mHealth solutions market. The report forecasts the revenue of the market segments with respect to five major regions. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, recent developments, and key market strategies.
Reasons to Buy the Report
This report will help established firms as well as new entrants and smaller firms gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or more of the following strategies to strengthen their positions in the market.
This report provides insights into:
• Analysis of key drivers (increasing penetration of smartphones, tablets, and other mobile platforms, increasing utilization of connected devices and mHealth apps to manage chronic diseases, cost containment in healthcare delivery, rising focus on patient-centric healthcare delivery, increasing demand for home healthcare services), restraints (lack of standards & regulations and sufficient reimbursement), opportunities (Growing adoption across emerging markets, growing adoption of mHealth solutions in mobile platforms), challenges (patent protection for mHealth devices and app, lack of data security and concerns regarding data theft and healthcare fraud) are factors contributing the growth of the mHealth solutions market.
• Product Development/Innovation: Detailed insights into upcoming trends, research & development activities, and software launches in the mHealth solutions market
• Market Development: Comprehensive information on lucrative emerging markets, type of offering, use case, end user, and region
• Market Diversification: Exhaustive information about software portfolios, growing geographies, recent developments, and investments in mHealth solutions market
• Competitive Assessment: In-depth assessment of market share, growth strategies, product offerings, company evaluation quadrant, and capabilities of leading players in the global mHealth solutions market, such as Koninklijke Philips N.V. (Netherlands), Medtronic (Ireland), Abbott (US), ResMed (US), Dexcom, Inc. (US), GE HealthCare (US), athenahealth (US), Optum (US), Teladoc Health (US), AliveCor, Inc. (US), among others
授權報價
| Single User Licence | $4,950 USD |
| Multi User Licence | $6,650 USD |
| Corporate User Licence | $8,150 USD |
| Global User Licence | $10,000 USD |
目錄 Table of Contents
1 INTRODUCTION 32
1.1 STUDY OBJECTIVES 32
1.2 MARKET DEFINITION 32
1.3 MARKET SCOPE 33
1.3.1 MARKET SEGMENTATION 33
1.3.2 INCLUSIONS & EXCLUSIONS 34
1.3.3 YEARS CONSIDERED 35
1.3.4 CURRENCY CONSIDERED 35
1.4 LIMITATIONS 36
1.5 STAKEHOLDERS 36
1.6 SUMMARY OF CHANGES 37
2 EXECUTIVE SUMMARY 38
2.1 KEY INSIGHTS AND MARKET HIGHLIGHTS 38
2.2 KEY MARKET PARTICIPANTS: SHARE INSIGHTS AND STRATEGIC DEVELOPMENTS 39
2.3 DISRUPTIVE TRENDS SHAPING MARKET 40
2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS 41
2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST 42
3 PREMIUM INSIGHTS 43
3.1 MHEALTH SOLUTIONS MARKET OVERVIEW 43
3.2 MHEALTH SOLUTIONS MARKET, BY OFFERING & REGION 44
3.3 MHEALTH SOLUTIONS MARKET: GEOGRAPHIC SNAPSHOT 45
4 MARKET OVERVIEW 46
4.1 INTRODUCTION 46
4.2 MARKET DYNAMICS 46
4.2.1 DRIVERS 47
4.2.1.1 Increasing penetration of smartphones, tablets, and other mobile platforms 47
4.2.1.2 Rising focus on patient-centric healthcare delivery 47
4.2.1.3 Rapid adoption of wearables expands connected mHealth ecosystems 48
4.2.1.4 Chronic disease burden drives demand for remote monitoring and connected devices 48
4.2.2 RESTRAINTS 49
4.2.2.1 Complexity of regulatory landscape 49
4.2.2.2 Fragmentation of mHealth ecosystem 49
4.2.2.3 Interoperability constraints 50
4.2.3 OPPORTUNITIES 50
4.2.3.1 AI and predictive analytics expand mHealth capabilities 50
4.2.3.2 Growing adoption across emerging markets 51
4.2.3.3 Strategic partnerships and collaborations among healthcare companies and mHealth providers 52
4.2.3.4 Telehealth growth expands mobile care delivery 52
4.2.4 CHALLENGES 53
4.2.4.1 Reimbursement barriers restrict wider mHealth adoption 53
4.2.4.2 Concerns associated with data security 53
4.2.4.3 Rapid Technology Evolution Increases mHealth Development Complexity 54
4.3 UNMET NEEDS AND WHITE SPACES 55
4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES 56
4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 56
5 INDUSTRY TRENDS 57
5.1 PORTER’S FIVE FORCES ANALYSIS 57
5.1.1 THREAT OF NEW ENTRANTS 58
5.1.2 THREAT OF SUBSTITUTES 58
5.1.3 BARGAINING POWER OF SUPPLIERS 59
5.1.4 BARGAINING POWER OF BUYERS 59
5.1.5 INTENSITY OF COMPETITIVE RIVALRY 59
5.2 MACROECONOMIC INDICATORS 59
5.2.1 INTRODUCTION 59
5.2.2 GDP TRENDS AND FORECAST 59
5.2.3 TRENDS IN GLOBAL HEALTHCARE IT INDUSTRY 60
5.3 VALUE CHAIN ANALYSIS 60
5.4 ECOSYSTEM ANALYSIS 61
5.5 PRICING ANALYSIS 62
5.5.1 INDICATIVE PRICE FOR MHEALTH SOLUTIONS, BY END USER (2025) 63
5.5.2 INDICATIVE PRICE FOR MHEALTH SOLUTIONS MARKET, BY REGION (2025) 63
5.6 KEY CONFERENCES AND EVENTS, 2026–2027 64
5.7 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 65
5.8 INVESTMENT AND FUNDING SCENARIO 65
5.9 CASE STUDY ANALYSIS 66
5.9.1 CASE 1: CASE STUDY 1: CLÍNICAS DEL AZÚCAR (CDA) 66
5.9.2 CASE STUDY 2: NOVA HOSPITAL & ENOVACOM 67
5.9.3 CASE STUDY 3: APPLE & NHS TEAMS 67
5.10 IMPACT OF 2025 US TARIFF – OVERVIEW 68
5.10.1 INTRODUCTION 68
5.10.2 KEY TARIFF RATES 69
5.10.3 PRICE IMPACT ANALYSIS 70
5.10.4 IMPACT ON COUNTRY/REGION 71
5.10.4.1 US 71
5.10.4.2 Europe 71
5.10.4.3 Asia Pacific 71
5.10.5 IMPACT ON END USERS 72
5.10.5.1 Healthcare providers 72
5.10.5.2 Healthcare payers 72
5.10.5.3 Patients and consumers 73
5.10.5.4 Other end users (Academic institutes, research centers, government bodies, etc.) 73
6 STRATEGIC DISRUPTION THROUGH TECHNOLOGY, PATENTS, DIGITAL,
AND AI ADOPTION 74
6.1 KEY EMERGING TECHNOLOGIES 74
6.1.1 AI AND MACHINE LEARNING 74
6.1.2 5G/6G CONNECTIVITY 74
6.1.3 DIGITAL BIOMARKERS 74
6.1.4 COMPLEMENTARY TECHNOLOGIES 74
6.1.5 CONNECTED MEDICAL DEVICES 74
6.1.6 CLOUD COMPUTING 75
6.1.7 TELEMEDICINE PLATFORMS 75
6.1.8 ADJACENT TECHNOLOGIES 75
6.1.8.1 Precision medicine 75
6.1.8.2 Clinical decision support systems 75
6.1.8.3 Healthcare data analytics 75
6.2 PATENT ANALYSIS 76
6.2.1 PATENT PUBLICATION TRENDS FOR THE MHEALTH SOLUTIONS 76
6.2.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 76
6.3 FUTURE APPLICATIONS 78
6.3.1 AI-POWERED PREDICTIVE HEALTH MONITORING 79
6.3.2 PERSONALIZED DIGITAL HEALTH COACHING 79
6.3.3 CONTINUOUS REMOTE PATIENT MONITORING 79
6.3.4 AI-ENABLED EARLY DISEASE DETECTION 79
6.3.5 MOBILE MEDICATION ADHERENCE AND MANAGEMENT 79
6.4 IMPACT OF AI/GEN AI ON MHEALTH SOLUTIONS MARKET 80
6.4.1 INTRODUCTION 80
6.4.2 MARKET POTENTIAL OF AI/GEN AI IN MHEALTH SOLUTIONS MARKET 81
6.4.3 CASE STUDIES RELATED TO AI/GEN AI IMPLEMENTATION 82
6.4.3.1 Cottage health expands AI-assisted virtual care and patient safety platform enterprise-wide 82
6.4.3.2 Apollo Hospitals deploys AI-enabled connected care across healthcare continuum 83
6.4.4 IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS 84
6.4.4.1 AI-powered symptom assessment & triage 84
6.4.4.2 Predictive health analytics 84
6.4.4.3 Conversational health assistants 85
6.4.4.4 Medication & treatment support 85
6.4.5 USER READINESS AND IMPACT ASSESSMENT 85
6.4.5.1 User readiness 85
6.4.5.1.1 Healthcare providers 85
6.4.5.1.2 Healthcare payers 85
6.4.5.1.3 Patients/Consumers 86
6.4.5.2 Impact assessment 86
6.4.5.2.1 User A: Healthcare providers 86
6.4.5.2.1.1 Implementation 86
6.4.5.2.1.2 Impact 86
6.4.5.2.2 User B: Healthcare payers 86
6.4.5.2.2.1 Implementation 86
6.4.5.2.2.2 Impact 87
6.4.5.2.3 User B: Patients/Consumers 87
6.4.5.2.3.1 Implementation 87
6.4.5.2.3.2 Impact 87
6.4.6 REGULATORY BODIES, GOVERNMENT AGENCIES, & OTHER ORGANIZATIONS 87
6.4.7 REGULATORY ANALYSIS 92
7 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 96
7.1 INTRODUCTION 96
7.2 DECISION-MAKING PROCESS 96
7.3 BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA 96
7.3.1 KEY STAKEHOLDERS IN BUYING PROCESS 97
7.3.2 BUYING CRITERIA 97
7.4 ADOPTION BARRIERS & INTERNAL CHALLENGES 98
7.5 UNMET NEEDS FROM VARIOUS END USERS 99
7.5.1 UNMET NEEDS 99
7.5.2 END USER EXPECTATIONS 100
7.6 MARKET PROFITABILITY 101
8 MHEALTH SOLUTIONS MARKET, BY OFFERING 102
8.1 INTRODUCTION 103
8.2 MHEALTH APPS 103
8.2.1 GROWING ADOPTION FOR PERSONALIZED AND CONNECTED HEALTHCARE TO DRIVE SEGMENT 103
8.2.2 CHRONIC CARE MANAGEMENT APPS 105
8.2.2.1 Increasing need for continuous, personalized chronic care management to boost demand 105
8.2.3 MENTAL & BEHAVIORAL HEALTH APPS 106
8.2.3.1 Growing demand for accessible and convenient mental healthcare to drive segment 106
8.2.4 GENERAL HEALTH & FITNESS APPS 107
8.2.4.1 Focus on personalized health, fitness, and wellness management to propel segment 107
8.2.5 MEDICATION MANAGEMENT & ADHERENCE APPS 108
8.2.5.1 Segment driven by need for improved medication adherence and treatment management 108
8.2.6 WOMEN’S HEALTH APPS 109
8.2.6.1 Rapid adoption of mobile technologies for personalized women’s health management 109
8.2.7 DIAGNOSTIC & SYMPTOM CHECKER APPS 110
8.2.7.1 Increasing need for convenient digital health assessment and diagnostic support to drive segment 110
8.2.8 PATIENT HEALTH RECORDS APPS/PATIENT PORTAL APPS 111
8.2.8.1 Growing need for accessible and connected patient health information to boost market 111
8.2.9 CLINICAL DECISION SUPPORT APPS 112
8.2.9.1 Rapid adoption of medical applications for clinical monitoring and decision support to drive segment 112
8.2.10 OTHER HEALTHCARE APPS 112
8.2.10.1 High demand for digital healthcare information and patient engagement to grow market 112
8.3 CONNECTED MEDICAL DEVICES 113
8.3.1 ADVANCING CONNECTED TECHNOLOGIES FOR CONTINUOUS AND PERSONALIZED HEALTH MONITORING TO DRIVE MARKET 113
8.3.2 VITAL SIGNS MONITORING DEVICES 115
8.3.2.1 Expanding role of connected monitoring in continuous patient assessment to boost segment 115
8.3.3 SLEEP MONITORING DEVICES 115
8.3.3.1 Advancing connected technologies for sleep health management 115
8.3.4 MULTIPARAMETER & REMOTE PATIENT MONITORING DEVICES 116
8.3.4.1 Increasing integration of multiparameter monitoring across care settings to boost market 116
8.3.5 FETAL & MATERNAL MONITORING DEVICES 117
8.3.5.1 Enhanced maternal and fetal care through wireless monitoring to drive segment 117
8.3.6 NEUROLOGICAL MONITORING DEVICES 118
8.3.6.1 Segment driven by advances in connected technologies for neurological monitoring 118
8.3.7 SMART INHALERS & DRUG DELIVERY DEVICES 119
8.3.7.1 Improved medication management through connected drug delivery to boost market 119
8.3.8 OTHER CONNECTED MEDICAL DEVICES 120
8.3.8.1 Broadening applications of connected devices in specialized healthcare 120
8.4 MHEALTH SERVICES 121
8.4.1 EXPANDING ACCESS TO CONNECTED AND PATIENT-CENTRIC HEALTHCARE SERVICES TO BOOST MARKET 121
8.4.2 REMOTE PATIENT MONITORING SERVICES 123
8.4.2.1 Extending clinical oversight beyond traditional care settings –
key driver 123
8.4.3 TELEHEALTH SERVICES 124
8.4.3.1 Broad access to virtual and on-demand healthcare to boost demand 124
8.4.4 DIGITAL DISEASE MANAGEMENT SERVICES 125
8.4.4.1 Shifting chronic disease management toward continuous digital care 125
8.4.5 OTHERS 126
8.4.5.1 Connected care strengthened through implementation, support, and digital rehabilitation 126
9 MHEALTH SOLUTIONS MARKET, BY USE CASE 127
9.1 INTRODUCTION 128
9.2 PREVENTIVE CARE & WELLNESS 128
9.2.1 AI AND WEARABLES DRIVE PREVENTIVE MHEALTH ADOPTION 128
9.3 SCREENING & DIAGNOSIS 129
9.3.1 MOBILE AND AI-ENABLED TOOLS EXPANDING ACCESS TO EARLY SCREENING & DIAGNOSIS 129
9.4 TREATMENT & DISEASE MANAGEMENT 130
9.4.1 CONNECTED DEVICES AND DIGITAL THERAPEUTICS STRENGTHENING MHEALTH-BASED DISEASE MANAGEMENT 130
9.5 PATIENT MONITORING 131
9.5.1 WEARABLES AND REMOTE MONITORING ENABLE CONTINUOUS PATIENT OVERSIGHT 131
9.6 MEDICATION MANAGEMENT & ADHERENCE 132
9.6.1 MOBILE PLATFORMS AND DIGITAL TOOLS IMPROVING MEDICATION ADHERENCE 132
9.7 CONSULTING & CARE COORDINATION 133
9.7.1 DIGITAL CONNECTIVITY ENABLES ENHANCED COORDINATED CARE DELIVERY 133
9.8 REHABILITATION & RECOVERY 134
9.8.1 DIGITAL REHABILITATION EXTENDS RECOVERY BEYOND TRADITIONAL THERAPY SETTINGS 134
9.9 OTHERS 135
9.9.1 MOBILE HEALTH EXPANDS POPULATION-LEVEL HEALTH EDUCATION AND AWARENESS 135
10 MHEALTH SOLUTIONS MARKET, BY END USER 137
10.1 INTRODUCTION 138
10.2 PATIENTS/CONSUMERS 138
10.2.1 PERSONALIZED AND CONVENIENT HEALTHCARE TO LEAD TO MARKET GROWTH 138
10.3 HEALTHCARE PROVIDERS 139
10.3.1 HEALTHCARE PROVIDERS INTEGRATING MHEALTH INTO
CONNECTED CARE DELIVERY 139
10.4 HEALTHCARE PAYERS 140
10.4.1 LEVERAGING MHEALTH TO IMPROVE OUTCOMES AND
MANAGE HEALTHCARE COSTS 140
10.5 OTHER END USERS 141
10.5.1 SCALED MHEALTH FOR POPULATION-LEVEL HEALTHCARE TO DRIVE SEGMENT 141
11 MHEALTH SOLUTIONS MARKET, BY REGION 143
11.1 INTRODUCTION 144
11.2 NORTH AMERICA 144
11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 146
11.2.2 US 150
11.2.2.1 Market driven by RPM and telehealth expansion 150
11.2.3 CANADA 154
11.2.3.1 Market driven by digital adoption and interoperability 154
11.3 EUROPE 158
11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 158
11.3.2 GERMANY 162
11.3.2.1 DiGA reimbursement and digital health integration to drive market 162
11.3.3 UK 166
11.3.3.1 Market driven by NHS digitalization and AI adoption 166
11.3.4 FRANCE 170
11.3.4.1 Market driven by telemonitoring and digital health infrastructure 170
11.3.5 ITALY 174
11.3.5.1 Market driven by PNRR, telemedicine, and EHR expansion 174
11.3.6 SPAIN 178
11.3.6.1 Rising funding for digital health plans to boost market 178
11.3.7 REST OF EUROPE 182
11.4 ASIA PACIFIC 186
11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 186
11.4.2 CHINA 191
11.4.2.1 Market driven by internet healthcare and AI-enabled care 191
11.4.3 JAPAN 195
11.4.3.1 Rising geriatric population and subsequent rise in preventive care to drive market 195
11.4.4 INDIA 199
11.4.4.1 Government initiatives and digital health to drive market growth 199
11.4.5 AUSTRALIA 203
11.4.5.1 Growing remote monitoring and connected health records expansion to drive market 203
11.4.6 SOUTH KOREA 207
11.4.6.1 Strategic partnerships and AI innovations accelerating mHealth adoption 207
11.4.7 REST OF ASIA PACIFIC 211
11.5 LATIN AMERICA 215
11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 215
11.5.2 BRAZIL 219
11.5.2.1 Market driven by SUS digitalization and connected care 219
11.5.3 MEXICO 223
11.5.3.1 Market driven by AI-enabled chronic care 223
11.5.4 REST OF LATIN AMERICA 227
11.6 MIDDLE EAST & AFRICA 231
11.7 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 231
11.7.1 GCC 235
11.7.1.1 Market driven by virtual hospitals and AI-enabled care 235
11.7.2 SAUDI ARABIA 239
11.7.2.1 Expanding connected healthcare ecosystem to boost market 239
11.7.3 UAE 243
11.7.3.1 Connected records and smart health apps to boost market 243
11.7.4 REST OF GCC 247
11.7.4.1 Strengthening of connected healthcare ecosystems through digital health transformation to propel market 247
11.7.5 SOUTH AFRICA 251
11.7.5.1 Market driven by mobile health and digital public healthcare 251
11.7.6 REST OF MIDDLE EAST & AFRICA 255
12 COMPETITIVE LANDSCAPE 259
12.1 INTRODUCTION 259
12.2 KEY PLAYER STRATEGY/RIGHT TO WIN 259
12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN MHEALTH SOLUTIONS MARKET 259
12.3 REVENUE ANALYSIS, 2021–2025 261
12.4 MARKET SHARE ANALYSIS, 2025 262
12.4.1 RANKING OF KEY MARKET PLAYERS 264
12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 265
12.5.1 STARS 265
12.5.2 EMERGING LEADERS 265
12.5.3 PERVASIVE PLAYERS 265
12.5.4 PARTICIPANTS 265
12.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 267
12.5.5.1 Company footprint 267
12.5.5.2 Regional footprint 268
12.5.5.3 Offering footprint 269
12.5.5.4 Use case footprint 270
12.5.5.5 End user footprint 271
12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025 272
12.6.1 PROGRESSIVE COMPANIES 272
12.6.2 RESPONSIVE COMPANIES 272
12.6.3 DYNAMIC COMPANIES 272
12.6.4 STARTING BLOCKS 272
12.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025 274
12.6.5.1 Detailed list of key startups/SMEs 274
12.6.5.2 Company footprint (startups/SMEs) 274
12.7 COMPANY VALUATION AND FINANCIAL METRICS 275
12.7.1 FINANCIAL METRICS 275
12.7.2 COMPANY VALUATION 275
12.8 BRAND/PRODUCT COMPARISON 276
12.9 COMPETITIVE SCENARIO 277
12.9.1 PRODUCT/SERVICE LAUNCHES & APPROVALS 277
12.9.2 DEALS 278
12.9.3 OTHER DEVELOPMENTS 279
13 COMPANY PROFILES 280
13.1 KEY PLAYERS 280
13.1.1 KONINKLIJKE PHILIPS N.V. 280
13.1.1.1 Business overview 280
13.1.1.2 Products & services offered 282
13.1.1.3 Recent developments 283
13.1.1.3.1 Product/Service launches & approvals 283
13.1.1.3.2 Deals 284
13.1.1.3.3 Expansions 286
13.1.1.3.4 Other developments 286
13.1.1.4 MnM view 287
13.1.1.4.1 Right to win 287
13.1.1.4.2 Strategic choices 287
13.1.1.4.3 Weaknesses & competitive threats 287
13.1.2 MEDTRONIC 288
13.1.2.1 Business overview 288
13.1.2.2 Products & services offered 290
13.1.2.3 Recent developments 291
13.1.2.3.1 Product/Service launches & approvals 291
13.1.2.3.2 Deals 292
13.1.2.4 MnM view 293
13.1.2.4.1 Right to win 293
13.1.2.4.2 Strategic choices 294
13.1.2.4.3 Weaknesses & competitive threats 294
13.1.3 ABBOTT 295
13.1.3.1 Business overview 295
13.1.3.2 Products & services offered 296
13.1.3.3 Recent developments 298
13.1.3.3.1 Product/Service launches & approvals 298
13.1.3.3.2 Deals 298
13.1.3.4 MnM view 299
13.1.3.4.1 Right to win 299
13.1.3.4.2 Strategic choices 299
13.1.3.4.3 Weaknesses & competitive threats 299
13.1.4 RESMED 300
13.1.4.1 Business overview 300
13.1.4.2 Products & services offered 302
13.1.4.3 Recent developments 303
13.1.4.3.1 Product/Service launches & approvals 303
13.1.4.3.2 Deals 304
13.1.4.4 MnM view 305
13.1.4.4.1 Right to win 305
13.1.4.4.2 Strategic choices 305
13.1.4.4.3 Weaknesses & competitive threats 305
13.1.5 DEXCOM, INC. 306
13.1.5.1 Business overview 306
13.1.5.2 Products & services offered 308
13.1.5.3 Recent developments 309
13.1.5.3.1 Product/Service launches & approvals 309
13.1.5.3.2 Deals 310
13.1.5.4 MnM view 311
13.1.5.4.1 Right to win 311
13.1.5.4.2 Strategic choices 311
13.1.5.4.3 Weaknesses & competitive threats 311
13.1.6 GE HEALTHCARE 312
13.1.6.1 Business overview 312
13.1.6.2 Products & services offered 313
13.1.6.3 Recent developments 314
13.1.6.3.1 Product/Service launches & approvals 314
13.1.6.3.2 Deals 315
13.1.6.3.3 Other developments 316
13.1.7 OMRON HEALTHCARE, INC. 317
13.1.7.1 Business overview 317
13.1.7.2 Products & services offered 318
13.1.7.3 Recent developments 319
13.1.7.3.1 Product/Service launches & approvals 319
13.1.7.4 Recent developments 320
13.1.7.4.1 Deals 320
13.1.8 ORACLE 321
13.1.8.1 Business overview 321
13.1.8.2 Products & services offered 322
13.1.8.3 Recent developments 323
13.1.8.3.1 Product/Service launches & approvals 323
13.1.8.3.2 Deals 323
13.1.8.3.3 Expansions 324
13.1.9 BOSTON SCIENTIFIC CORPORATION 325
13.1.9.1 Business overview 325
13.1.9.2 Products & services offered 326
13.1.9.3 Recent developments 327
13.1.9.3.1 Product/Service launches & approvals 327
13.1.9.4 Recent developments 327
13.1.9.4.1 Deals 327
13.1.10 SIEMENS HEALTHCARE PRIVATE LIMITED 328
13.1.10.1 Business overview 328
13.1.10.2 Products & services offered 329
13.1.10.3 Recent developments 330
13.1.10.3.1 Product/Service launches & approvals 330
13.1.10.3.2 Expansions 330
13.1.11 OPTUM 331
13.1.11.1 Business overview 331
13.1.11.2 Products & services offered 332
13.1.11.3 Recent developments 333
13.1.11.3.1 Deals 333
13.1.12 ATHENAHEALTH 334
13.1.12.1 Business overview 334
13.1.12.2 Products & services offered 334
13.1.12.3 Recent developments 335
13.1.12.3.1 Product/Service launches & approvals 335
13.1.12.3.2 Deals, January 2023-July 2026 335
13.1.13 EMPATICA INC. 336
13.1.13.1 Business overview 336
13.1.13.2 Products & services offered 336
13.1.13.3 Recent developments 337
13.1.13.3.1 Product/Service launches & approvals 337
13.1.13.3.2 Deals 338
13.1.13.3.3 Expansions 339
13.1.14 TELADOC HEALTH, INC. 340
13.1.14.1 Business overview 340
13.1.14.2 Products & services offered 341
13.1.14.3 Recent developments 342
13.1.14.3.1 Product/Service launches & approvals 342
13.1.14.3.2 Deals 343
13.1.15 WELLDOC, INC. 344
13.1.15.1 Business overview 344
13.1.15.2 Products & services offered 344
13.1.15.3 Recent developments 345
13.1.15.3.1 Product/Service launches & approvals 345
13.1.15.3.2 Deals 345
13.1.16 ALIVECOR, INC. 347
13.1.16.1 Business overview 347
13.1.16.2 Products & services offered 347
13.1.16.3 Recent developments 348
13.1.16.3.1 Product/Service launches & approvals 348
13.1.16.3.2 Deals 349
13.1.17 BIOFOURMIS 350
13.1.17.1 Business overview 350
13.1.17.2 Products & services offered 350
13.1.17.3 Recent developments 351
13.1.17.3.1 Deals 351
13.1.18 TUNSTALL GROUP 352
13.1.18.1 Business overview 352
13.1.18.2 Products & services offered 352
13.1.19 GARMIN LTD. 353
13.1.19.1 Business overview 353
13.1.19.2 Products & services offered 354
13.1.19.3 Recent developments 355
13.1.19.3.1 Product/Service launches & approvals 355
13.1.19.3.2 Deals 356
13.1.20 AIRSTRIP TECHNOLOGIES, INC 357
13.1.20.1 Business overview 357
13.1.20.2 Products & services offered 357
13.1.20.3 Recent developments 358
13.1.20.3.1 Product/Service launches & approvals 358
13.1.20.3.2 Deals 359
13.2 OTHER PLAYERS 360
13.2.1 NATURAL CYCLES NORDIC AB 360
13.2.2 SIDEKICK HEALTH 361
13.2.3 BUOY HEALTH, INC. 362
13.2.4 VIASUALDX 363
13.2.5 FIMO HEALTH 364
14 RESEARCH METHODOLOGY 365
14.1 RESEARCH DATA 365
14.1.1 SECONDARY DATA 366
14.1.1.1 Key data from secondary sources 366
14.1.2 PRIMARY DATA 367
14.1.2.1 Key data from primary sources 368
14.1.2.2 Breakdown of primary sources 369
14.2 MARKET SIZE ESTIMATION 370
14.3 MARKET SIZE ESTIMATION 371
14.4 MARKET BREAKDOWN DATA TRIANGULATION 376
14.5 MARKET SHARE ESTIMATION 377
14.6 STUDY ASSUMPTIONS 377
14.7 RESEARCH LIMITATIONS 377
14.7.1 METHODOLOGY-RELATED LIMITATIONS 377
14.8 RISK ASSESSMENT 378
15 APPENDIX 379
15.1 DISCUSSION GUIDE 379
15.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 384
15.3 CUSTOMIZATION OPTIONS 386
15.4 RELATED REPORTS 386
15.5 AUTHOR DETAILS 387
圖表清單 List of Tables & Figures
TABLE 1 USD EXCHANGE RATES 36
TABLE 2 MHEALTH SOLUTIONS MARKET: IMPACT ANALYSIS 55
TABLE 3 MHEALTH SOLUTIONS MARKET: PORTER’S FIVE FORCES ANALYSIS 57
TABLE 4 MHEALTH SOLUTIONS MARKET: ROLE IN ECOSYSTEM 62
TABLE 5 INDICATIVE PRICE FOR MHEALTH SOLUTIONS, BY END USER (2025) 63
TABLE 6 INDICATIVE PRICE FOR MHEALTH SOLUTIONS, BY REGION (2025) 64
TABLE 7 MHEALTH SOLUTIONS MARKET: KEY CONFERENCES & EVENTS, 2026–2027 64
TABLE 8 US ADJUSTED RECIPROCAL TARIFF RATES 69
TABLE 9 JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES FOR MHEALTH SOLUTIONS MARKET 76
TABLE 10 MHEALTH SOLUTIONS MARKET: KEY PATENTS/PATENT APPLICATIONS 78
TABLE 11 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 87
TABLE 12 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 88
TABLE 13 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 90
TABLE 14 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 91
TABLE 15 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 91
TABLE 16 NORTH AMERICA: REGULATORY ANALYSIS 92
TABLE 17 EUROPE: REGULATORY ANALYSIS 93
TABLE 18 ASIA PACIFIC: REGULATORY ANALYSIS 94
TABLE 19 MIDDLE EAST & AFRICA: REGULATORY ANALYSIS 95
TABLE 20 LATIN AMERICA: REGULATORY ANALYSIS 95
TABLE 21 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF
TOP THREE END USERS (%) 97
TABLE 22 KEY BUYING CRITERIA FOR TOP THREE END USERS 98
TABLE 23 UNMET NEEDS IN MHEALTH SOLUTIONS MARKET 99
TABLE 24 END USER EXPECTATIONS IN MHEALTH SOLUTIONS MARKET 100
TABLE 25 MHEALTH SOLUTIONS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 103
TABLE 26 MHEALTH SOLUTIONS MARKET FOR MHEALTH APPS, BY TYPE,
2024–2031 (USD MILLION) 104
TABLE 27 MHEALTH SOLUTIONS MARKET FOR MHEALTH APPS, BY REGION,
2024–2031 (USD MILLION) 105
TABLE 28 MHEALTH SOLUTIONS MARKET FOR CHRONIC CARE MANAGEMENT APPS,
BY REGION, 2024–2031 (USD MILLION) 106
TABLE 29 MHEALTH SOLUTIONS MARKET FOR MENTAL & BEHAVIORAL HEALTH APPS,
BY REGION, 2024–2031 (USD MILLION) 107
TABLE 30 MHEALTH SOLUTIONS MARKET FOR GENERAL HEALTH & FITNESS APPS,
BY REGION, 2024–2031 (USD MILLION) 108
TABLE 31 MHEALTH SOLUTIONS MARKET FOR MEDICATION MANAGEMENT &
ADHERENCE APPS, BY REGION, 2024–2031 (USD MILLION) 109
TABLE 32 MHEALTH SOLUTIONS MARKET FOR WOMEN’S HEALTH APPS, BY REGION,
2024–2031 (USD MILLION) 110
TABLE 33 MHEALTH SOLUTIONS MARKET FOR DIAGNOSTIC & SYMPTOM CHECKER APPS,
BY REGION, 2024–2031 (USD MILLION) 111
TABLE 34 MHEALTH SOLUTIONS MARKET FOR PATIENT HEALTH RECORDS APPS/PATIENT PORTAL APPS, BY REGION, 2024–2031 (USD MILLION) 111
TABLE 35 MHEALTH SOLUTIONS MARKET FOR CLINICAL DECISION SUPPORT APPS,
BY REGION, 2024–2031 (USD MILLION) 112
TABLE 36 MHEALTH SOLUTIONS MARKET FOR OTHER HEALTHCARE APPS, BY REGION, 2024–2031 (USD MILLION) 113
TABLE 37 MHEALTH SOLUTIONS MARKET FOR CONNECTED MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION) 114
TABLE 38 MHEALTH SOLUTIONS MARKET FOR CONNECTED MEDICAL DEVICES, BY REGION, 2024–2031 (USD MILLION) 114
TABLE 39 MHEALTH SOLUTIONS MARKET FOR VITAL SIGNS MONITORING DEVICES,
BY REGION, 2024–2031 (USD MILLION) 115
TABLE 40 MHEALTH SOLUTIONS MARKET FOR SLEEP MONITORING DEVICES, BY REGION, 2024–2031 (USD MILLION) 116
TABLE 41 MHEALTH SOLUTIONS MARKET FOR MULTIPARAMETER & REMOTE PATIENT MONITORING DEVICES, BY REGION, 2024–2031 (USD MILLION) 117
TABLE 42 MHEALTH SOLUTIONS MARKET FOR FETAL & MATERNAL MONITORING DEVICES, BY REGION, 2024–2031 (USD MILLION) 118
TABLE 43 MHEALTH SOLUTIONS MARKET FOR NEUROLOGICAL MONITORING DEVICES,
BY REGION, 2024–2031 (USD MILLION) 119
TABLE 44 MHEALTH SOLUTIONS MARKET FOR SMART INHALERS & DRUG DELIVERY DEVICES, BY REGION, 2024–2031 (USD MILLION) 120
TABLE 45 MHEALTH SOLUTIONS MARKET FOR OTHER CONNECTED MEDICAL DEVICES,
BY REGION, 2024–2031 (USD MILLION) 121
TABLE 46 MHEALTH SOLUTIONS MARKET FOR MHEALTH SERVICES, BY TYPE,
2024–2031 (USD MILLION) 122
TABLE 47 MHEALTH SOLUTIONS MARKET FOR MHEALTH SERVICES, BY REGION,
2024–2031 (USD MILLION) 122
TABLE 48 MHEALTH SOLUTIONS MARKET FOR REMOTE PATIENT MONITORING SERVICES,
BY REGION, 2024–2031 (USD MILLION) 123
TABLE 49 MHEALTH SOLUTIONS MARKET FOR TELEHEALTH SERVICES, BY REGION,
2024–2031 (USD MILLION) 124
TABLE 50 MHEALTH SOLUTIONS MARKET FOR DIGITAL DISEASE MANAGEMENT SERVICES, BY REGION, 2024–2031 (USD MILLION) 125
TABLE 51 MHEALTH SOLUTIONS MARKET FOR OTHER SERVICES, BY REGION,
2024–2031 (USD MILLION) 126
TABLE 52 MHEALTH SOLUTIONS MARKET, BY USE CASE, 2024–2031 (USD MILLION) 128
TABLE 53 MHEALTH SOLUTIONS MARKET FOR PREVENTIVE CARE & WELLNESS, BY REGION, 2024–2031 (USD MILLION) 129
TABLE 54 MHEALTH SOLUTIONS MARKET FOR SCREENING & DIAGNOSIS, BY REGION,
2024–2031 (USD MILLION) 130
TABLE 55 MHEALTH SOLUTIONS MARKET FOR TREATMENT & DISEASE MANAGEMENT,
BY REGION, 2024–2031 (USD MILLION) 131
TABLE 56 MHEALTH SOLUTIONS MARKET FOR PATIENT MONITORING, BY REGION,
2024–2031 (USD MILLION) 132
TABLE 57 MHEALTH SOLUTIONS MARKET FOR MEDICATION MANAGEMENT & ADHERENCE, BY REGION, 2024–2031 (USD MILLION) 133
TABLE 58 MHEALTH SOLUTIONS MARKET FOR CONSULTING & CARE COORDINATION,
BY REGION, 2024–2031 (USD MILLION) 134
TABLE 59 MHEALTH SOLUTIONS MARKET FOR REHABILITATION & RECOVERY, BY REGION, 2024–2031 (USD MILLION) 135
TABLE 60 MHEALTH SOLUTIONS MARKET FOR OTHER USE CASES, BY REGION,
2024–2031 (USD MILLION) 136
TABLE 61 MHEALTH SOLUTIONS MARKET, BY END USER, 2024–2031 (USD MILLION) 138
TABLE 62 MHEALTH SOLUTIONS MARKET FOR PATIENTS/CONSUMERS, BY REGION,
2024–2031 (USD MILLION) 139
TABLE 63 MHEALTH SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY REGION,
2024–2031 (USD MILLION) 140
TABLE 64 MHEALTH SOLUTIONS MARKET FOR HEALTHCARE PAYERS, BY REGION,
2024–2031 (USD MILLION) 141
TABLE 65 MHEALTH SOLUTIONS MARKET FOR OTHER END USERS, BY REGION,
2024–2031 (USD MILLION) 142
TABLE 66 MHEALTH SOLUTIONS MARKET, BY REGION, 2024–2031 (USD MILLION) 144
TABLE 67 NORTH AMERICA: MHEALTH SOLUTIONS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 146
TABLE 68 NORTH AMERICA: MHEALTH SOLUTIONS MARKET, BY OFFERING,
2024–2031 (USD MILLION) 146
TABLE 69 NORTH AMERICA: MHEALTH SOLUTIONS MARKET FOR MHEALTH APPS,
BY TYPE, 2024–2031 (USD MILLION) 147
TABLE 70 NORTH AMERICA: MHEALTH SOLUTIONS MARKET FOR CONNECTED
MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION) 148
TABLE 71 NORTH AMERICA: MHEALTH SOLUTIONS MARKET FOR MHEALTH SERVICES,
BY TYPE, 2024–2031 (USD MILLION) 148
TABLE 72 NORTH AMERICA: MHEALTH SOLUTIONS MARKET, BY USE CASE,
2024–2031 (USD MILLION) 149
TABLE 73 NORTH AMERICA: MHEALTH SOLUTIONS MARKET, BY END USER,
2024–2031 (USD MILLION) 149
TABLE 74 US: MHEALTH SOLUTIONS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 150
TABLE 75 US: MHEALTH SOLUTIONS MARKET FOR MHEALTH APPS, BY TYPE,
2024–2031 (USD MILLION) 151
TABLE 76 US: MHEALTH SOLUTIONS MARKET FOR CONNECTED MEDICAL DEVICES,
BY TYPE, 2024–2031 (USD MILLION) 152
TABLE 77 US: MHEALTH SOLUTIONS MARKET FOR MHEALTH SERVICES, BY TYPE,
2024–2031 (USD MILLION) 152
TABLE 78 US: MHEALTH SOLUTIONS MARKET, BY USE CASE, 2024–2031 (USD MILLION) 153
TABLE 79 US: MHEALTH SOLUTIONS MARKET, BY END USER, 2024–2031 (USD MILLION) 153
TABLE 80 CANADA: MHEALTH SOLUTIONS MARKET, BY OFFERING,
2024–2031 (USD MILLION) 154
TABLE 81 CANADA: MHEALTH SOLUTIONS MARKET FOR MHEALTH APPS, BY TYPE,
2024–2031 (USD MILLION) 155
TABLE 82 CANADA: MHEALTH SOLUTIONS MARKET FOR CONNECTED MEDICAL DEVICES,
BY TYPE, 2024–2031 (USD MILLION) 156
TABLE 83 CANADA: MHEALTH SOLUTIONS MARKET FOR MHEALTH SERVICES,
BY TYPE, 2024–2031 (USD MILLION) 156
TABLE 84 CANADA: MHEALTH SOLUTIONS MARKET, BY USE CASE,
2024–2031 (USD MILLION) 157
TABLE 85 CANADA: MHEALTH SOLUTIONS MARKET, BY END USER,
2024–2031 (USD MILLION) 157
TABLE 86 EUROPE: MHEALTH SOLUTIONS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 158
TABLE 87 EUROPE: MHEALTH SOLUTIONS MARKET, BY OFFERING,
2024–2031 (USD MILLION) 159
TABLE 88 EUROPE: MHEALTH SOLUTIONS MARKET FOR MHEALTH APPS, BY TYPE,
2024–2031 (USD MILLION) 159
TABLE 89 EUROPE: MHEALTH SOLUTIONS MARKET FOR CONNECTED MEDICAL DEVICES,
BY TYPE, 2024–2031 (USD MILLION) 160
TABLE 90 EUROPE: MHEALTH SOLUTIONS MARKET FOR MHEALTH SERVICES,
BY TYPE, 2024–2031 (USD MILLION) 160
TABLE 91 EUROPE: MHEALTH SOLUTIONS MARKET, BY USE CASE,
2024–2031 (USD MILLION) 161
TABLE 92 EUROPE: MHEALTH SOLUTIONS MARKET, BY END USER,
2024–2031 (USD MILLION) 161
TABLE 93 GERMANY: MHEALTH SOLUTIONS MARKET, BY OFFERING,
2024–2031 (USD MILLION) 163
TABLE 94 GERMANY: MHEALTH SOLUTIONS MARKET FOR MHEALTH APPS, BY TYPE,
2024–2031 (USD MILLION) 163
TABLE 95 GERMANY: MHEALTH SOLUTIONS MARKET FOR CONNECTED MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION) 164
TABLE 96 GERMANY: MHEALTH SOLUTIONS MARKET FOR MHEALTH SERVICES,
BY TYPE, 2024–2031 (USD MILLION) 164
TABLE 97 GERMANY: MHEALTH SOLUTIONS MARKET, BY USE CASE,
2024–2031 (USD MILLION) 165
TABLE 98 GERMANY: MHEALTH SOLUTIONS MARKET, BY END USER,
2024–2031 (USD MILLION) 165
TABLE 99 UK: MHEALTH SOLUTIONS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 167
TABLE 100 UK: MHEALTH SOLUTIONS MARKET FOR MHEALTH APPS, BY TYPE,
2024–2031 (USD MILLION) 167
TABLE 101 UK: MHEALTH SOLUTIONS MARKET FOR CONNECTED MEDICAL DEVICES,
BY TYPE, 2024–2031 (USD MILLION) 168
TABLE 102 UK: MHEALTH SOLUTIONS MARKET FOR MHEALTH SERVICES, BY TYPE,
2024–2031 (USD MILLION) 168
TABLE 103 UK: MHEALTH SOLUTIONS MARKET, BY USE CASE, 2024–2031 (USD MILLION) 169
TABLE 104 UK: MHEALTH SOLUTIONS MARKET, BY END USER, 2024–2031 (USD MILLION) 169
TABLE 105 FRANCE: MHEALTH SOLUTIONS MARKET, BY OFFERING,
2024–2031 (USD MILLION) 170
TABLE 106 FRANCE: MHEALTH SOLUTIONS MARKET FOR MHEALTH APPS, BY TYPE,
2024–2031 (USD MILLION) 171
TABLE 107 FRANCE: MHEALTH SOLUTIONS MARKET FOR CONNECTED MEDICAL DEVICES,
BY TYPE, 2024–2031 (USD MILLION) 172
TABLE 108 FRANCE: MHEALTH SOLUTIONS MARKET FOR MHEALTH SERVICES,
BY TYPE, 2024–2031 (USD MILLION) 172
TABLE 109 FRANCE: MHEALTH SOLUTIONS MARKET, BY USE CASE,
2024–2031 (USD MILLION) 173
TABLE 110 FRANCE: MHEALTH SOLUTIONS MARKET, BY END USER,
2024–2031 (USD MILLION) 173
TABLE 111 ITALY: MHEALTH SOLUTIONS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 174
TABLE 112 ITALY: MHEALTH SOLUTIONS MARKET FOR MHEALTH APPS, BY TYPE,
2024–2031 (USD MILLION) 175
TABLE 113 ITALY: MHEALTH SOLUTIONS MARKET FOR CONNECTED MEDICAL DEVICES,
BY TYPE, 2024–2031 (USD MILLION) 176
TABLE 114 ITALY: MHEALTH SOLUTIONS MARKET FOR MHEALTH SERVICES, BY TYPE,
2024–2031 (USD MILLION) 176
TABLE 115 ITALY: MHEALTH SOLUTIONS MARKET, BY USE CASE, 2024–2031 (USD MILLION) 177
TABLE 116 ITALY: MHEALTH SOLUTIONS MARKET, BY END USER, 2024–2031 (USD MILLION) 177
TABLE 117 SPAIN: MHEALTH SOLUTIONS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 178
TABLE 118 SPAIN: MHEALTH SOLUTIONS MARKET FOR MHEALTH APPS, BY TYPE,
2024–2031 (USD MILLION) 179
TABLE 119 SPAIN: MHEALTH SOLUTIONS MARKET FOR CONNECTED MEDICAL DEVICES,
BY TYPE, 2024–2031 (USD MILLION) 180
TABLE 120 SPAIN: MHEALTH SOLUTIONS MARKET FOR MHEALTH SERVICES, BY TYPE,
2024–2031 (USD MILLION) 180
TABLE 121 SPAIN: MHEALTH SOLUTIONS MARKET, BY USE CASE, 2024–2031 (USD MILLION) 181
TABLE 122 SPAIN: MHEALTH SOLUTIONS MARKET, BY END USER, 2024–2031 (USD MILLION) 181
TABLE 123 REST OF EUROPE: MHEALTH SOLUTIONS MARKET, BY OFFERING,
2024–2031 (USD MILLION) 182
TABLE 124 REST OF EUROPE: MHEALTH SOLUTIONS MARKET FOR MHEALTH APPS,
BY TYPE, 2024–2031 (USD MILLION) 183
TABLE 125 REST OF EUROPE: MHEALTH SOLUTIONS MARKET FOR CONNECTED MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION) 184
TABLE 126 REST OF EUROPE: MHEALTH SOLUTIONS MARKET FOR MHEALTH SERVICES,
BY TYPE, 2024–2031 (USD MILLION) 184
TABLE 127 REST OF EUROPE: MHEALTH SOLUTIONS MARKET, BY USE CASE,
2024–2031 (USD MILLION) 185
TABLE 128 REST OF EUROPE: MHEALTH SOLUTIONS MARKET, BY END USER,
2024–2031 (USD MILLION) 185
TABLE 129 ASIA PACIFIC: MHEALTH SOLUTIONS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 187
TABLE 130 ASIA PACIFIC: MHEALTH SOLUTIONS MARKET, BY OFFERING,
2024–2031 (USD MILLION) 188
TABLE 131 ASIA PACIFIC: MHEALTH SOLUTIONS MARKET FOR MHEALTH APPS,
BY TYPE, 2024–2031 (USD MILLION) 188
TABLE 132 ASIA PACIFIC: MHEALTH SOLUTIONS MARKET FOR CONNECTED MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION) 189
TABLE 133 ASIA PACIFIC: MHEALTH SOLUTIONS MARKET FOR MHEALTH SERVICES,
BY TYPE, 2024–2031 (USD MILLION) 189
TABLE 134 ASIA PACIFIC: MHEALTH SOLUTIONS MARKET, BY USE CASE,
2024–2031 (USD MILLION) 190
TABLE 135 ASIA PACIFIC: MHEALTH SOLUTIONS MARKET, BY END USER,
2024–2031 (USD MILLION) 190
TABLE 136 CHINA: MHEALTH SOLUTIONS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 191
TABLE 137 CHINA: MHEALTH SOLUTIONS MARKET FOR MHEALTH APPS, BY TYPE,
2024–2031 (USD MILLION) 192
TABLE 138 CHINA: MHEALTH SOLUTIONS MARKET FOR CONNECTED MEDICAL DEVICES,
BY TYPE, 2024–2031 (USD MILLION) 193
TABLE 139 CHINA: MHEALTH SOLUTIONS MARKET FOR MHEALTH SERVICES, BY TYPE,
2024–2031 (USD MILLION) 194
TABLE 140 CHINA: MHEALTH SOLUTIONS MARKET, BY USE CASE, 2024–2031 (USD MILLION) 194
TABLE 141 CHINA: MHEALTH SOLUTIONS MARKET, BY END USER, 2024–2031 (USD MILLION) 195
TABLE 142 JAPAN: MHEALTH SOLUTIONS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 196
TABLE 143 JAPAN: MHEALTH SOLUTIONS MARKET FOR MHEALTH APPS, BY TYPE,
2024–2031 (USD MILLION) 196
TABLE 144 JAPAN: MHEALTH SOLUTIONS MARKET FOR CONNECTED MEDICAL DEVICES,
BY TYPE, 2024–2031 (USD MILLION) 197
TABLE 145 JAPAN: MHEALTH SOLUTIONS MARKET FOR MHEALTH SERVICES, BY TYPE,
2024–2031 (USD MILLION) 197
TABLE 146 JAPAN: MHEALTH SOLUTIONS MARKET, BY USE CASE, 2024–2031 (USD MILLION) 198
TABLE 147 JAPAN: MHEALTH SOLUTIONS MARKET, BY END USER, 2024–2031 (USD MILLION) 198
TABLE 148 INDIA: MHEALTH SOLUTIONS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 199
TABLE 149 INDIA: MHEALTH SOLUTIONS MARKET FOR MHEALTH APPS, BY TYPE,
2024–2031 (USD MILLION) 200
TABLE 150 INDIA: MHEALTH SOLUTIONS MARKET FOR CONNECTED MEDICAL DEVICES,
BY TYPE, 2024–2031 (USD MILLION) 201
TABLE 151 INDIA: MHEALTH SOLUTIONS MARKET FOR MHEALTH SERVICES, BY TYPE,
2024–2031 (USD MILLION) 201
TABLE 152 INDIA: MHEALTH SOLUTIONS MARKET, BY USE CASE, 2024–2031 (USD MILLION) 202
TABLE 153 INDIA: MHEALTH SOLUTIONS MARKET, BY END USER, 2024–2031 (USD MILLION) 202
TABLE 154 AUSTRALIA: MHEALTH SOLUTIONS MARKET, BY OFFERING,
2024–2031 (USD MILLION) 203
TABLE 155 AUSTRALIA: MHEALTH SOLUTIONS MARKET FOR MHEALTH APPS, BY TYPE,
2024–2031 (USD MILLION) 204
TABLE 156 AUSTRALIA: MHEALTH SOLUTIONS MARKET FOR CONNECTED MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION) 205
TABLE 157 AUSTRALIA: MHEALTH SOLUTIONS MARKET FOR MHEALTH SERVICES, BY TYPE, 2024–2031 (USD MILLION) 205
TABLE 158 AUSTRALIA: MHEALTH SOLUTIONS MARKET, BY USE CASE,
2024–2031 (USD MILLION) 206
TABLE 159 AUSTRALIA: MHEALTH SOLUTIONS MARKET, BY END USER,
2024–2031 (USD MILLION) 206
TABLE 160 SOUTH KOREA: MHEALTH SOLUTIONS MARKET, BY OFFERING,
2024–2031 (USD MILLION) 207
TABLE 161 SOUTH KOREA: MHEALTH SOLUTIONS MARKET FOR MHEALTH APPS,
BY TYPE, 2024–2031 (USD MILLION) 208
TABLE 162 SOUTH KOREA: MHEALTH SOLUTIONS MARKET FOR CONNECTED MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION) 209
TABLE 163 SOUTH KOREA: MHEALTH SOLUTIONS MARKET FOR MHEALTH SERVICES,
BY TYPE, 2024–2031 (USD MILLION) 209
TABLE 164 SOUTH KOREA: MHEALTH SOLUTIONS MARKET, BY USE CASE,
2024–2031 (USD MILLION) 210
TABLE 165 SOUTH KOREA: MHEALTH SOLUTIONS MARKET, BY END USER,
2024–2031 (USD MILLION) 210
TABLE 166 REST OF ASIA PACIFIC: MHEALTH SOLUTIONS MARKET, BY OFFERING,
2024–2031 (USD MILLION) 211
TABLE 167 REST OF ASIA PACIFIC: MHEALTH SOLUTIONS MARKET FOR MHEALTH APPS,
BY TYPE, 2024–2031 (USD MILLION) 212
TABLE 168 REST OF ASIA PACIFIC: MHEALTH SOLUTIONS MARKET FOR CONNECTED MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION) 213
TABLE 169 REST OF ASIA PACIFIC: MHEALTH SOLUTIONS MARKET FOR MHEALTH SERVICES, BY TYPE, 2024–2031 (USD MILLION) 213
TABLE 170 REST OF ASIA PACIFIC: MHEALTH SOLUTIONS MARKET, BY USE CASE,
2024–2031 (USD MILLION) 214
TABLE 171 REST OF ASIA PACIFIC: MHEALTH SOLUTIONS MARKET, BY END USER,
2024–2031 (USD MILLION) 214
TABLE 172 LATIN AMERICA: MHEALTH SOLUTIONS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 215
TABLE 173 LATIN AMERICA: MHEALTH SOLUTIONS MARKET, BY OFFERING,
2024–2031 (USD MILLION) 216
TABLE 174 LATIN AMERICA: MHEALTH SOLUTIONS MARKET FOR MHEALTH APPS,
BY TYPE, 2024–2031 (USD MILLION) 216
TABLE 175 LATIN AMERICA: MHEALTH SOLUTIONS MARKET FOR CONNECTED MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION) 217
TABLE 176 LATIN AMERICA: MHEALTH SOLUTIONS MARKET FOR MHEALTH SERVICES,
BY TYPE, 2024–2031 (USD MILLION) 217
TABLE 177 LATIN AMERICA: MHEALTH SOLUTIONS MARKET, BY USE CASE,
2024–2031 (USD MILLION) 218
TABLE 178 LATIN AMERICA: MHEALTH SOLUTIONS MARKET, BY END USER,
2024–2031 (USD MILLION) 218
TABLE 179 BRAZIL: MHEALTH SOLUTIONS MARKET, BY OFFERING,
2024–2031 (USD MILLION) 219
TABLE 180 BRAZIL: MHEALTH SOLUTIONS MARKET FOR MHEALTH APPS, BY TYPE,
2024–2031 (USD MILLION) 220
TABLE 181 BRAZIL: MHEALTH SOLUTIONS MARKET FOR CONNECTED MEDICAL DEVICES,
BY TYPE, 2024–2031 (USD MILLION) 221
TABLE 182 BRAZIL: MHEALTH SOLUTIONS MARKET FOR MHEALTH SERVICES, BY TYPE,
2024–2031 (USD MILLION) 221
TABLE 183 BRAZIL: MHEALTH SOLUTIONS MARKET, BY USE CASE, 2024–2031 (USD MILLION) 222
TABLE 184 BRAZIL: MHEALTH SOLUTIONS MARKET, BY END USER,
2024–2031 (USD MILLION) 222
TABLE 185 MEXICO: MHEALTH SOLUTIONS MARKET, BY OFFERING,
2024–2031 (USD MILLION) 223
TABLE 186 MEXICO: MHEALTH SOLUTIONS MARKET FOR MHEALTH APPS, BY TYPE,
2024–2031 (USD MILLION) 224
TABLE 187 MEXICO: MHEALTH SOLUTIONS MARKET FOR CONNECTED MEDICAL DEVICES,
BY TYPE, 2024–2031 (USD MILLION) 225
TABLE 188 MEXICO: MHEALTH SOLUTIONS MARKET FOR MHEALTH SERVICES,
BY TYPE, 2024–2031 (USD MILLION) 225
TABLE 189 MEXICO: MHEALTH SOLUTIONS MARKET, BY USE CASE,
2024–2031 (USD MILLION) 226
TABLE 190 MEXICO: MHEALTH SOLUTIONS MARKET, BY END USER,
2024–2031 (USD MILLION) 226
TABLE 191 REST OF LATIN AMERICA: MHEALTH SOLUTIONS MARKET,
BY OFFERING, 2024–2031 (USD MILLION) 227
TABLE 192 REST OF LATIN AMERICA: MHEALTH SOLUTIONS MARKET FOR MHEALTH APPS,
BY TYPE, 2024–2031 (USD MILLION) 228
TABLE 193 REST OF LATIN AMERICA: MHEALTH SOLUTIONS MARKET FOR CONNECTED MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION) 229
TABLE 194 REST OF LATIN AMERICA: MHEALTH SOLUTIONS MARKET FOR MHEALTH SERVICES, BY TYPE, 2024–2031 (USD MILLION) 229
TABLE 195 REST OF LATIN AMERICA: MHEALTH SOLUTIONS MARKET, BY USE CASE,
2024–2031 (USD MILLION) 230
TABLE 196 REST OF LATIN AMERICA: MHEALTH SOLUTIONS MARKET, BY END USER,
2024–2031 (USD MILLION) 230
TABLE 197 MIDDLE EAST & AFRICA: MHEALTH SOLUTIONS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 231
TABLE 198 MIDDLE EAST & AFRICA: MHEALTH SOLUTIONS MARKET, BY OFFERING,
2024–2031 (USD MILLION) 232
TABLE 199 MIDDLE EAST & AFRICA: MHEALTH SOLUTIONS MARKET FOR MHEALTH APPS,
BY TYPE, 2024–2031 (USD MILLION) 232
TABLE 200 MIDDLE EAST & AFRICA: MHEALTH SOLUTIONS MARKET FOR CONNECTED MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION) 233
TABLE 201 MIDDLE EAST & AFRICA: MHEALTH SOLUTIONS MARKET FOR MHEALTH SERVICES, BY TYPE, 2024–2031 (USD MILLION) 233
TABLE 202 MIDDLE EAST & AFRICA: MHEALTH SOLUTIONS MARKET, BY USE CASE,
2024–2031 (USD MILLION) 234
TABLE 203 MIDDLE EAST & AFRICA: MHEALTH SOLUTIONS MARKET, BY END USER,
2024–2031 (USD MILLION) 234
TABLE 204 GCC: MHEALTH SOLUTIONS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 235
TABLE 205 GCC: MHEALTH SOLUTIONS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 236
TABLE 206 GCC: MHEALTH SOLUTIONS MARKET FOR MHEALTH APPS, BY TYPE,
2024–2031 (USD MILLION) 236
TABLE 207 GCC: MHEALTH SOLUTIONS MARKET FOR CONNECTED MEDICAL DEVICES,
BY TYPE, 2024–2031 (USD MILLION) 237
TABLE 208 GCC: MHEALTH SOLUTIONS MARKET FOR MHEALTH SERVICES, BY TYPE,
2024–2031 (USD MILLION) 237
TABLE 209 GCC: MHEALTH SOLUTIONS MARKET, BY USE CASE, 2024–2031 (USD MILLION) 238
TABLE 210 GCC: MHEALTH SOLUTIONS MARKET, BY END USER, 2024–2031 (USD MILLION) 238
TABLE 211 SAUDI ARABIA: MHEALTH SOLUTIONS MARKET, BY OFFERING,
2024–2031 (USD MILLION) 239
TABLE 212 SAUDI ARABIA: MHEALTH SOLUTIONS MARKET FOR MHEALTH APPS,
BY TYPE, 2024–2031 (USD MILLION) 240
TABLE 213 SAUDI ARABIA: MHEALTH SOLUTIONS MARKET FOR CONNECTED
MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION) 241
TABLE 214 SAUDI ARABIA: MHEALTH SOLUTIONS MARKET FOR MHEALTH SERVICES,
BY TYPE, 2024–2031 (USD MILLION) 241
TABLE 215 SAUDI ARABIA: MHEALTH SOLUTIONS MARKET, BY USE CASE,
2024–2031 (USD MILLION) 242
TABLE 216 SAUDI ARABIA: MHEALTH SOLUTIONS MARKET, BY END USER,
2024–2031 (USD MILLION) 242
TABLE 217 UAE: MHEALTH SOLUTIONS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 243
TABLE 218 UAE: MHEALTH SOLUTIONS MARKET FOR MHEALTH APPS, BY TYPE,
2024–2031 (USD MILLION) 244
TABLE 219 UAE: MHEALTH SOLUTIONS MARKET FOR CONNECTED MEDICAL DEVICES,
BY TYPE, 2024–2031 (USD MILLION) 245
TABLE 220 UAE: MHEALTH SOLUTIONS MARKET FOR MHEALTH SERVICES, BY TYPE,
2024–2031 (USD MILLION) 245
TABLE 221 UAE: MHEALTH SOLUTIONS MARKET, BY USE CASE, 2024–2031 (USD MILLION) 246
TABLE 222 UAE: MHEALTH SOLUTIONS MARKET, BY END USER, 2024–2031 (USD MILLION) 246
TABLE 223 REST OF GCC: MHEALTH SOLUTIONS MARKET, BY OFFERING,
2024–2031 (USD MILLION) 247
TABLE 224 REST OF GCC: MHEALTH SOLUTIONS MARKET FOR MHEALTH APPS, BY TYPE, 2024–2031 (USD MILLION) 248
TABLE 225 REST OF GCC: MHEALTH SOLUTIONS MARKET FOR CONNECTED MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION) 249
TABLE 226 REST OF GCC: MHEALTH SOLUTIONS MARKET FOR MHEALTH SERVICES,
BY TYPE, 2024–2031 (USD MILLION) 249
TABLE 227 REST OF GCC: MHEALTH SOLUTIONS MARKET, BY USE CASE,
2024–2031 (USD MILLION) 250
TABLE 228 REST OF GCC: MHEALTH SOLUTIONS MARKET, BY END USER,
2024–2031 (USD MILLION) 250
TABLE 229 SOUTH AFRICA: MHEALTH SOLUTIONS MARKET, BY OFFERING,
2024–2031 (USD MILLION) 251
TABLE 230 SOUTH AFRICA: MHEALTH SOLUTIONS MARKET FOR MHEALTH APPS,
BY TYPE, 2024–2031 (USD MILLION) 252
TABLE 231 SOUTH AFRICA: MHEALTH SOLUTIONS MARKET FOR CONNECTED MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION) 253
TABLE 232 SOUTH AFRICA: MHEALTH SOLUTIONS MARKET FOR MHEALTH SERVICES,
BY TYPE, 2024–2031 (USD MILLION) 253
TABLE 233 SOUTH AFRICA: MHEALTH SOLUTIONS MARKET, BY USE CASE,
2024–2031 (USD MILLION) 254
TABLE 234 SOUTH AFRICA: MHEALTH SOLUTIONS MARKET, BY END USER,
2024–2031 (USD MILLION) 254
TABLE 235 REST OF MIDDLE EAST & AFRICA: MHEALTH SOLUTIONS MARKET,
BY OFFERING, 2024–2031 (USD MILLION) 255
TABLE 236 REST OF MIDDLE EAST & AFRICA: MHEALTH SOLUTIONS MARKET FOR MHEALTH APPS, BY TYPE, 2024–2031 (USD MILLION) 256
TABLE 237 REST OF MIDDLE EAST & AFRICA: MHEALTH SOLUTIONS MARKET FOR CONNECTED MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION) 257
TABLE 238 REST OF MIDDLE EAST & AFRICA: MHEALTH SOLUTIONS MARKET FOR MHEALTH SERVICES, BY TYPE, 2024–2031 (USD MILLION) 257
TABLE 239 REST OF MIDDLE EAST & AFRICA: MHEALTH SOLUTIONS MARKET,
BY USE CASE, 2024–2031 (USD MILLION) 258
TABLE 240 REST OF MIDDLE EAST & AFRICA: MHEALTH SOLUTIONS MARKET,
BY END USER, 2024–2031 (USD MILLION) 258
TABLE 241 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN MHEALTH SOLUTIONS MARKET, JANUARY 2023–JUNE 2026 259
TABLE 242 MHEALTH SOLUTIONS MARKET SHARE ANALYSIS, 2025 263
TABLE 243 MHEALTH SOLUTIONS MARKET: REGIONAL FOOTPRINT, 2025 268
TABLE 244 MHEALTH SOLUTIONS MARKET: OFFERING FOOTPRINT, 2025 269
TABLE 245 MHEALTH SOLUTIONS MARKET: USE CASE FOOTPRINT, 2025 270
TABLE 246 MHEALTH SOLUTIONS MARKET: END USER FOOTPRINT, 2025 271
TABLE 247 MHEALTH SOLUTIONS MARKET: DETAILED LIST OF KEY STARTUP/
SME PLAYERS, 2025 274
TABLE 248 MHEALTH SOLUTIONS MARKET: REGIONAL FOOTPRINT (STARTUPS/SMES), 2025 274
TABLE 249 MHEALTH SOLUTIONS MARKET: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2023–AUGUST 2026 277
TABLE 250 MHEALTH SOLUTIONS MARKET: DEALS, JANUARY 2023–AUGUST 2026 278
TABLE 251 MHEALTH SOLUTIONS MARKET: EXPANSIONS, JANUARY 2023–AUGUST 2026 279
TABLE 252 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW 280
TABLE 253 KONINKLIJKE PHILIPS N.V.: PRODUCTS & SERVICES OFFERED 282
TABLE 254 KONINKLIJKE PHILIPS N.V.: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2023−AUGUST 2026 283
TABLE 255 KONINKLIJKE PHILIPS N.V.: DEALS, JANUARY 2023-JULY 2026 284
TABLE 256 KONINKLIJKE PHILIPS N.V.: EXPANSIONS, JANUARY 2023-JULY 2026,
JANUARY 2023−AUGUST 2026 286
TABLE 257 KONINKLIJKE PHILIPS N.V.: OTHER DEVELOPMENTS,
JANUARY 2023–AUGUST 2026 286
TABLE 258 MEDTRONIC: COMPANY OVERVIEW 288
TABLE 259 MEDTRONIC: PRODUCTS & SERVICES OFFERED 290
TABLE 260 MEDTRONIC: PRODUCT/SERVICE LAUNCHES & APPROVALS,
JANUARY 2023−AUGUST 2026 291
TABLE 261 MEDTRONIC: DEALS, JANUARY 2023-AUGUST 2026 292
TABLE 262 ABBOTT: COMPANY OVERVIEW 295
TABLE 263 ABBOTT: PRODUCTS & SERVICES OFFERED 296
TABLE 264 ABBOTT: PRODUCT/SERVICE LAUNCHES & APPROVALS,
JANUARY 2023−AUGUST 2026 298
TABLE 265 ABBOTT: DEALS, JANUARY 2023-AUGUST 2026 298
TABLE 266 RESMED: COMPANY OVERVIEW 300
TABLE 267 RESMED: PRODUCTS & SERVICES OFFERED 302
TABLE 268 RESMED: PRODUCT/SERVICE LAUNCHES & APPROVALS,
JANUARY 2023−AUGUST 2026 303
TABLE 269 RESMED, INC.: DEALS, JANUARY 2023-AUGUST 2026 304
TABLE 270 DEXCOM, INC.: COMPANY OVERVIEW 306
TABLE 271 DEXCOM, INC.: PRODUCTS & SERVICES OFFERED 308
TABLE 272 DEXCOM, INC.: PRODUCT/SERVICE LAUNCHES & APPROVALS,
JANUARY 2023−AUGUST 2026 309
TABLE 273 DEXCOM, INC.: DEALS, JANUARY 2023–AUGUST 2026 310
TABLE 274 GE HEALTHCARE: COMPANY OVERVIEW 312
TABLE 275 GE HEALTHCARE: PRODUCTS & SERVICES OFFERED 313
TABLE 276 GE HEALTHCARE: PRODUCT/SERVICE LAUNCHES & APPROVALS,
JANUARY 2023−AUGUST 2026 314
TABLE 277 GE HEALTHCARE: DEALS, JANUARY 2023-AUGUST 2026 315
TABLE 278 GE HEALTHCARE: OTHER DEVELOPMENTS, JANUARY 2023–AUGUST 2026 316
TABLE 279 OMRON HEALTHCARE, INC.: COMPANY OVERVIEW 317
TABLE 280 OMRON HEALTHCARE, INC.: PRODUCTS & SERVICES OFFERED 318
TABLE 281 OMRON HEALTHCARE, INC.: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2023−AUGUST 2026 319
TABLE 282 OMRON HEALTHCARE, INC.: DEALS, JANUARY 2023–AUGUST 2026 320
TABLE 283 ORACLE: COMPANY OVERVIEW 321
TABLE 284 ORACLE: PRODUCTS & SERVICES OFFERED 322
TABLE 285 ORACLE: PRODUCT/SERVICE LAUNCHES & APPROVALS,
JANUARY 2023−AUGUST 2026 323
TABLE 286 ORACLE: DEALS, JANUARY 2023–AUGUST 2026 323
TABLE 287 ORACLE: EXPANSIONS, JANUARY 2023-AUGUST 2026 324
TABLE 288 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW 325
TABLE 289 BOSTON SCIENTIFIC CORPORATION: PRODUCTS & SERVICES OFFERED 326
TABLE 290 BOSTON SCIENTIFIC CORPORATION: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2023−AUGUST 2026 327
TABLE 291 BOSTON SCIENTIFIC CORPORATION: DEALS, JANUARY 2023–AUGUST 2026 327
TABLE 292 SIEMENS HEALTHCARE PRIVATE LIMITED: COMPANY OVERVIEW 328
TABLE 293 SIEMENS HEALTHCARE PRIVATE LIMITED: PRODUCTS & SERVICES OFFERED 329
TABLE 294 SIEMENS HEALTHINEERS: PRODUCT/SERVICE LAUNCHES & APPROVALS,
JANUARY 2023−AUGUST 2026 330
TABLE 295 SIEMENS HEALTHCARE PRIVATE LIMITED: EXPANSIONS,
JANUARY 2023–AUGUST 2026 330
TABLE 296 OPTUM: COMPANY OVERVIEW 331
TABLE 297 OPTUM: PRODUCTS & SERVICES OFFERED 332
TABLE 298 OPTUM: DEALS, JANUARY 2023-AUGUST 2026 333
TABLE 299 ATHENAHEALTH: COMPANY OVERVIEW 334
TABLE 300 ATHENAHEALTH: PRODUCTS & SERVICES OFFERED 334
TABLE 301 ATHENAHEALTH: PRODUCT/SERVICE LAUNCHES & APPROVALS,
JANUARY 2023−AUGUST 2026 335
TABLE 302 ATHENAHEALTH: DEALS, JANUARY 2023-AUGUST 2026 335
TABLE 303 EMPATICA INC.: COMPANY OVERVIEW 336
TABLE 304 EMPATICA INC.: PRODUCTS & SERVICES OFFERED 336
TABLE 305 EMPATICA INC.: PRODUCT/SERVICE LAUNCHES & APPROVALS,
JANUARY 2023−AUGUST 2026 337
TABLE 306 EMPATICA INC.: DEALS, JANUARY 2023–AUGUST 2026 338
TABLE 307 EMPATICA INC.: EXPANSIONS, JANUARY 2023–AUGUST 2026 339
TABLE 308 TELADOC HEALTH, INC.: COMPANY OVERVIEW 340
TABLE 309 TELADOC HEALTH, INC.: PRODUCTS & SERVICES OFFERED 341
TABLE 310 TELADOC HEALTH, INC.: PRODUCT/SERVICE LAUNCHES & APPROVALS,
JANUARY 2023−AUGUST 2026 342
TABLE 311 TELADOC HEALTH, INC.: DEALS, JANUARY 2023–AUGUST 2026 343
TABLE 312 WELLDOC, INC.: COMPANY OVERVIEW 344
TABLE 313 WELLDOC, INC.: PRODUCTS & SERVICES OFFERED 344
TABLE 314 WELLDOC, INC.: PRODUCT/SERVICE LAUNCHES & APPROVALS,
JANUARY 2023−AUGUST 2026 345
TABLE 315 WELLDOC, INC.: DEALS, JANUARY 2023–AUGUST 2026 345
TABLE 316 ALIVECOR, INC. COMPANY OVERVIEW 347
TABLE 317 ALIVECOR, INC. PRODUCTS & SERVICES OFFERED 347
TABLE 318 ALIVECOR, INC.: PRODUCT/SERVICE LAUNCHES & APPROVALS,
JANUARY 2023−AUGUST 2026 348
TABLE 319 ALIVECOR, INC.: DEALS, JANUARY 2023–AUGUST 2026 349
TABLE 320 BIOFOURMIS: COMPANY OVERVIEW 350
TABLE 321 BIOFOURMIS: PRODUCTS & SERVICES OFFERED 350
TABLE 322 BIOFOURMIS: DEALS, JANUARY 2023–AUGUST 2026 351
TABLE 323 TUNSTALL GROUP: COMPANY OVERVIEW 352
TABLE 324 TUNSTALL GROUP: PRODUCTS & SERVICES OFFERED 352
TABLE 325 GARMIN LTD.: COMPANY OVERVIEW 353
TABLE 326 GARMIN LTD.: PRODUCTS & SERVICES OFFERED 354
TABLE 327 GARMIN LTD.: PRODUCT/SERVICE LAUNCHES & APPROVALS,
JANUARY 2023−AUGUST 2026 355
TABLE 328 GARMIN LTD.: DEALS, JANUARY 2023–AUGUST 2026 356
TABLE 329 AIRSTRIP TECHNOLOGIES, INC: COMPANY OVERVIEW 357
TABLE 330 AIRSTRIP TECHNOLOGIES, INC: PRODUCTS & SERVICES OFFERED 357
TABLE 331 AIRSTRIP TECHNOLOGIES, INC.: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2023−AUGUST 2026 358
TABLE 332 AIRSTRIP TECHNOLOGIES, INC.: DEALS, JANUARY 2023–AUGUST 2026 359
TABLE 333 RISK ASSESSMENT: MHEALTH SOLUTIONS MARKET 378
FIGURE 1 MHEALTH SOLUTIONS MARKET SEGMENTATION 33
FIGURE 2 MARKET SCENARIO 38
FIGURE 3 GLOBAL MHEATLH SOLUTIONS MARKET, 2024–2031 39
FIGURE 4 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN MHEATLH
SOLUTIONS MARKET, 2022–2026 39
FIGURE 5 DISRUPTIONS INFLUENCING GROWTH OF MHEATLH SOLUTIONS MARKET 40
FIGURE 6 HIGH-GROWTH SEGMENTS IN MHEATLH SOLUTIONS MARKET, 2026–2031 41
FIGURE 7 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN MHEATLH SOLUTIONS MARKET DURING FORECAST PERIOD 42
FIGURE 8 GROWING ADOPTION OF TELEHEALTH AND REMOTE CARE TO DRIVE MARKET 43
FIGURE 9 MHEALTH APPS IN NORTH AMERICA ACCOUNTED FOR LARGEST
MARKET SHARE IN 2025 44
FIGURE 10 INDIA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 45
FIGURE 11 MHEALTH SOLUTIONS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 46
FIGURE 12 MHEALTH SOLUTIONS MARKET: PORTER’S FIVE FORCES ANALYSIS 58
FIGURE 13 MHEALTH SOLUTIONS MARKET: VALUE CHAIN ANALYSIS 60
FIGURE 14 MHEALTH SOLUTIONS MARKET: ECOSYSTEM ANALYSIS 62
FIGURE 15 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 65
FIGURE 17 JURISDICTION AND TOP APPLICANT ANALYSIS FOR MHEALTH SOLUTIONS MARKET 76
FIGURE 18 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR MHEALTH MARKET (JANUARY 2015 TO DECEMBER 2025) 77
FIGURE 19 MARKET POTENTIAL OF AI/GEN AI IN MHEALTH SOLUTIONS 81
FIGURE 20 IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS 84
FIGURE 21 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS 97
FIGURE 22 KEY BUYING CRITERIA FOR TOP THREE END USERS 98
FIGURE 23 NORTH AMERICA: MHEALTH SOLUTIONS MARKET SNAPSHOT 145
FIGURE 24 ASIA PACIFIC: MHEALTH SOLUTIONS MARKET SNAPSHOT 187
FIGURE 25 REVENUE ANALYSIS OF KEY PLAYERS IN MHEALTH SOLUTIONS MARKET,
2021–2025 262
FIGURE 26 MHEALTH SOLUTIONS MARKET SHARE ANALYSIS OF KEY PLAYERS, 2025 263
FIGURE 27 RANKING OF KEY PLAYERS IN MHEALTH SOLUTIONS MARKET, 2025 264
FIGURE 28 MHEALTH SOLUTIONS MARKET: COMPANY EVALUATION MATRIX
(KEY PLAYERS), 2025 266
FIGURE 29 MHEALTH SOLUTIONS MARKET: COMPANY FOOTPRINT, 2025 267
FIGURE 30 MHEALTH SOLUTIONS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025 273
FIGURE 31 EV/EBITDA OF KEY VENDORS, 2026 275
FIGURE 32 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA
OF KEY VENDORS, 2026 275
FIGURE 33 MHEALTH SOLUTIONS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 276
FIGURE 34 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2025) 281
FIGURE 35 MEDTRONIC: COMPANY SNAPSHOT (2025) 289
FIGURE 36 ABBOTT: COMPANY SNAPSHOT (2025) 296
FIGURE 37 RESMED: COMPANY SNAPSHOT (2026) 301
FIGURE 38 DEXCOM, INC.: COMPANY SNAPSHOT (2025) 307
FIGURE 39 GE HEALTHCARE: COMPANY SNAPSHOT (2025) 313
FIGURE 40 OMRON HEALTHCARE: COMPANY SNAPSHOT (2024) 318
FIGURE 41 ORACLE: COMPANY SNAPSHOT (2026) 322
FIGURE 42 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2025) 326
FIGURE 43 SIEMENS HEALTHCARE PRIVATE LIMITED: COMPANY SNAPSHOT (2025) 329
FIGURE 44 OPTUM: COMPANY SNAPSHOT (2025) 332
FIGURE 45 TELADOC HEALTH, INC.: COMPANY SNAPSHOT (2025) 341
FIGURE 46 GARMIN LTD.: COMPANY SNAPSHOT (2025) 354
FIGURE 47 RESEARCH DESIGN 365
FIGURE 48 PRIMARY SOURCES 367
FIGURE 49 INSIGHTS FROM INDUSTRY EXPERTS 369
FIGURE 50 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,
DESIGNATION, AND REGION 369
FIGURE 51 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 370
FIGURE 52 BOTTOM-UP APPROACH 371
FIGURE 53 TOP-DOWN APPROACH 372
FIGURE 54 CAGR PROJECTIONS FROM ANALYSIS OF DROC IN MHEALTH SOLUTIONS INDUSTRY 373
FIGURE 55 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 374
FIGURE 56 DATA TRIANGULATION METHODOLOGY 376
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們